A Collection of Current In-Demand COVID-19 Related Products

As the COVID-19 pandemic keeps spreading around the world with no sign of slowing down, massive research about drugs, vaccines, and other therapies is in full swing to mitigate the negative impact on human well-being.

BOC Sciences offers several related products that show great benefits to the anti-epidemic activities. These include SARS-CoV-2 inhibitors and key raw materials for the production of disinfectants, test reagents, and vaccines.

SARS-CoV-2 Inhibitors

Vaccines are widely recognized as the best way to terminate the pandemic. Nevertheless, due to the emergence of new SARS-CoV-2 variants, it's inevitable to see decreasing effectiveness. Moreover, many citizens show unwillingness to be vaccinated, leading to a non-ideal vaccination rate. All challenges noted above imply that other therapeutics are still essential to co-work with vaccines.

Under the circumstances, antibodies and other viral entry inhibitors appear to be a valuable supplement thanks to their potential to reduce hospitalizations, prevent chronic late effects, and lower the death rate. The inspiration for developing effective antivirals originates from a thorough exploration of virus structure. The same is true for SARS-CoV-2 inhibitor research. Since the first epidemic outbreak in late 2019, scientists and pharmaceutical enterprises as well as many chemical suppliers like BOC Sciences have been intensively engaged in research about the main targets—S protein, TMPRSS2, ACE2, RdRp, Mpro, etc.

All the efforts pay off with a number of SARS-CoV-2 related inhibitors released on the market. BOC Sciences alone can offer over 100 hit inhibitors to facilitate drug innovation against COVID-19, including but not limited to Lopinavir and Remdesivir.

Raw Materials for Disinfectant

In addition to increasing vaccination effectiveness and rate, and exploring new therapies and drugs, CDC suggests a few ways especially proper hygiene to block the spread of viruses as preventive steps.

Facing the rapidly growing need for disinfectants production, many chemical suppliers have fought tooth and nail to provide key materials for disinfectant manufacturers. For instance, BOC Sciences has tried to diversify its offerings that can be used in different formulations for disinfectants, hand sanitizers, and other cleaning products. Thanks to the concerted efforts of dedicated researchers, the most in-demand products—Carbomer 940/980 are now in secured stable supply to form clear gel.

Raw Materials for Test Reagents

Testing for COVID-19. That’s not a stranger for everyone throughout the world. According to the official report of WHO, there are three categories of testing: 1. NAAT test (N-A-A-T) is the PCR testing where people would have a nasal pharyngeal swab or a pharyngeal swab taken to look for the genetic material of the virus. 2. Antigen testing is a method of trying to detect the outer protein of the virus. 3. Test for antibodies shows whether the immune response has been developed within the human body.

Owing to the high-level accuracy, PCR testing is quite prevalent among medical institutions, government procurement departments, and other individuals that need tests for COVID-19. BOC Sciences, with years of expertise in the (bio)chemical industry, also works at full capacity to supply essential materials for testing kit production and self-immunity vaccine development, such as a series of instant premixed granules to study cell biology, biomedicals, solutions, and reagents.

Vaccine Related Products

Among the 100+ vaccines under development, the new-type mRNA nucleic acid vaccine outshines because of the advantages of a short R&D period, relative safety, long immune response time, short production period, and nearly no risk of integration into host DNA.

BOC Sciences has in-stock basic nucleotide raw materials, modified nucleotide materials, cap analogs, polynucleotide tails, and custom RNA synthesis services to support the urgent research and production of mRNA vaccines. Besides, vaccine adjuvants are provided to initiate innate immune response induced by antigens, ultimately bringing improved vaccine efficacy.

Conclusion

Backed by the powerful and inventive supply chain, scientists are convinced that more effective vaccines, drugs, and therapies will come out to win the battle. BOC Sciences and its peers are also striving to see the final triumph.